CVKD

Cadrenal Therapeutics Inc

$3.35

0.33 (10.93%) Today

— up— down

Market Cap

$9M-72.4%

Revenue (TTM)

$0

$0

Net Income (TTM)

$-16,220,666

$-16,220,666

EPS (TTM)

-5.65

-5.65

Shares Out

2.87M

2.87M

Open

$2.97

$2.97

Previous Close

$3.02

$3.02

Day Range

$2.97 – $3.35

$2.97 – $3.35

52-Week Range

$2.55 – $14.64

$2.55 – $14.64

Beta

1.85

1.85

Volume

12.21K

12.21K

Avg Volume

62.54K

62.54K

Analyst Rating

Buy

Buy

Exchange

NASDAQ NMS - GLOBAL MARKET

NASDAQ NMS - GLOBAL MARKET

About CVKD

Related

News

Cadrenal Therapeutics Appoints John P. Sharp As Interim CFO Effective June 25, 2026; Quang X. Pham Ceases To Serve As Interim CFO

Benzinga · 1d ago

Cadrenal Therapeutics Says Late-Breaking Clinical Data On 12-Lipoxygenase Inhibitor, CAD-1005, Accepted For Oral Presentation At 34th Congress Of ISTH

Benzinga · 6d ago